LKB1 Signaling and Patient Survival Outcomes in Hepatocellular Carcinoma.

[1]  Yan Li,et al.  RNF126 contributes to stem cell-like properties and metastasis in hepatocellular carcinoma through ubiquitination and degradation of LKB1 , 2022, Human Cell.

[2]  Lei Hu,et al.  AMPKα2/HNF4A/BORIS/GLUT4 pathway promotes hepatocellular carcinoma cell invasion and metastasis in low glucose microenviroment. , 2022, Biochemical pharmacology.

[3]  B. Manavathi,et al.  AMPK: An odyssey of a metabolic regulator, a tumor suppressor, and now a contextual oncogene. , 2022, Biochimica et biophysica acta. Reviews on cancer.

[4]  Ming Yang,et al.  LKB1 inhibits proliferation, metastasis and angiogenesis of thyroid cancer by upregulating SIK1 , 2022, Journal of Cancer.

[5]  E. Martin,et al.  Liver Kinase B1 Regulates Remodeling of the Tumor Microenvironment in Triple-Negative Breast Cancer , 2022, Frontiers in Molecular Biosciences.

[6]  M. Ladanyi,et al.  Salt-Inducible Kinase 1 is a potential therapeutic target in Desmoplastic Small Round Cell Tumor , 2022, Oncogenesis.

[7]  J. Roth,et al.  TUSC2 immunogene enhances efficacy of chemo-immuno combination on KRAS/LKB1 mutant NSCLC in humanized mouse model , 2022, Communications biology.

[8]  Lavanya Ponnusamy,et al.  MARK2/4 promotes Warburg effect and cell growth in non-small cell lung carcinoma through the AMPKα1/mTOR/HIF-1α signaling pathway. , 2022, Biochimica et biophysica acta. Molecular cell research.

[9]  F. Lee,et al.  AMPK promotes Arf6 activation in a kinase-independent manner upon glucose starvation , 2021, bioRxiv.

[10]  P. Ma,et al.  Salt‐inducible kinase 2 functions as a tumor suppressor in hepatocellular carcinoma , 2021, Environmental toxicology.

[11]  A. Moustakas,et al.  NUAK1 and NUAK2 Fine-Tune TGF-β Signaling , 2021, Cancers.

[12]  Qiang Huang,et al.  miR-451 suppresses EMT and metastasis in glioma cells , 2021, Cell cycle.

[13]  D. Drewry,et al.  Evaluation of liver kinase B1 downstream signaling expression in various breast cancers and relapse free survival after systemic chemotherapy treatment , 2021, Oncotarget.

[14]  Jingru Liu,et al.  Critical Role of Lkb1 in the Maintenance of Alveolar Macrophage Self-Renewal and Immune Homeostasis , 2021, Frontiers in Immunology.

[15]  Biomed Research International.  Retracted: MiR-451 Promotes Cell Proliferation and Metastasis in Pancreatic Cancer through Targeting CAB39 , 2021, BioMed research international.

[16]  J. Relova,et al.  Concurrent Akt, ERK1/2 and AMPK Activation by Obestatin Inhibits Apoptotic Signaling Cascades on Nutrient-Deprived PC12 Cells , 2021, Cellular and molecular neurobiology.

[17]  J. Rao,et al.  Circular RNA circGSK3B Promotes Cell Proliferation, Migration, and Invasion by Sponging miR-1265 and Regulating CAB39 Expression in Hepatocellular Carcinoma , 2020, Frontiers in Oncology.

[18]  Ling He,et al.  HPV16 E6/E7 promote the translocation and glucose uptake of GLUT1 by PI3K/AKT pathway via relieving miR-451 inhibitory effect on CAB39 in lung cancer cells , 2020, Therapeutic advances in chronic disease.

[19]  R. Ramchandran,et al.  SNRK: a metabolic regulator with multifaceted role in development and disease , 2020, Vessel plus.

[20]  Jian-ping Guo,et al.  The potent roles of salt-inducible kinases (SIKs) in metabolic homeostasis and tumorigenesis , 2020, Signal Transduction and Targeted Therapy.

[21]  J. Xing,et al.  SIK2 promotes reprogramming of glucose metabolism through PI3K/AKT/HIF-1α pathway and Drp1-mediated mitochondrial fission in ovarian cancer. , 2020, Cancer letters.

[22]  Y. Liang,et al.  MiR-107 confers chemoresistance to colorectal cancer by targeting calcium-binding protein 39 , 2020, British Journal of Cancer.

[23]  S. Indraccolo,et al.  LKB1/AMPK Pathway and Drug Response in Cancer: A Therapeutic Perspective , 2019, Oxidative medicine and cellular longevity.

[24]  J. Yun,et al.  AMPKα1 confers survival advantage of colorectal cancer cells under metabolic stress by promoting redox balance through the regulation of glutathione reductase phosphorylation , 2019, Oncogene.

[25]  Simin Liu,et al.  Dysregulation of PP2A-Akt interaction contributes to Sucrose non-fermenting related kinase (SNRK) deficiency induced insulin resistance in adipose tissue , 2019, Molecular metabolism.

[26]  Xinchen Sun,et al.  Salt-Inducible Kinase 2: An Oncogenic Signal Transmitter and Potential Target for Cancer Therapy , 2019, Front. Oncol..

[27]  C. Heldin,et al.  Transforming growth factor β (TGFβ) induces NUAK kinase expression to fine-tune its signaling output , 2019, The Journal of Biological Chemistry.

[28]  B. Győrffy,et al.  Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma , 2018, Royal Society Open Science.

[29]  Alicia M. Salvi,et al.  Mechanisms linking mechanotransduction and cell metabolism. , 2018, Current opinion in cell biology.

[30]  A. Nikitin,et al.  CAMKK2 Promotes Prostate Cancer Independently of AMPK via Increased Lipogenesis. , 2018, Cancer research.

[31]  Jun Yu,et al.  CAB39L elicited an anti-Warburg effect via a LKB1-AMPK-PGC1α axis to inhibit gastric tumorigenesis , 2018, Oncogene.

[32]  Ö. Sahin,et al.  SIK2 attenuates proliferation and survival of breast cancer cells with simultaneous perturbation of MAPK and PI3K/Akt pathways , 2018, Oncotarget.

[33]  Sheng-nan Wu,et al.  SNRK (Sucrose Nonfermenting 1-Related Kinase) Promotes Angiogenesis In Vivo , 2018, Arteriosclerosis, thrombosis, and vascular biology.

[34]  T. Shan,et al.  Lkb1 regulation of skeletal muscle development, metabolism and muscle progenitor cell homeostasis , 2017, Journal of cellular physiology.

[35]  R. Ramchandran,et al.  Sucrose Non-Fermenting Related Kinase Expression in Ovarian Cancer and Correlation with Clinical Features , 2017, Cancer investigation.

[36]  N. Na,et al.  BRSK2 induced by nutrient deprivation promotes Akt activity in pancreatic cancer via downregulation of mTOR activity , 2017, Oncotarget.

[37]  N. Yoo,et al.  Putative Tumor Suppressor Genes EGR1 and BRSK1 Are Mutated in Gastric and Colorectal Cancers , 2016, Oncology.

[38]  R. Bast,et al.  A Novel Compound ARN-3236 Inhibits Salt-Inducible Kinase 2 and Sensitizes Ovarian Cancer Cell Lines and Xenografts to Paclitaxel , 2016, Clinical Cancer Research.

[39]  D. F. Chedom,et al.  Salt-Inducible Kinase 2 Couples Ovarian Cancer Cell Metabolism with Survival at the Adipocyte-Rich Metastatic Niche. , 2016, Cancer cell.

[40]  Yuling Chen,et al.  Downregulation of HSP60 disrupts mitochondrial proteostasis to promote tumorigenesis and progression in clear cell renal cell carcinoma , 2016, Oncotarget.

[41]  Lizhe Wang,et al.  Salt-inducible Kinase (SIK1) regulates HCC progression and WNT/β-catenin activation. , 2016, Journal of hepatology.

[42]  Junnian Zheng,et al.  The diverse oncogenic and tumor suppressor roles of salt-inducible kinase (SIK) in cancer , 2016, Expert opinion on therapeutic targets.

[43]  M. Sekiya,et al.  Stabilization of Microtubule-Unbound Tau via Tau Phosphorylation at Ser262/356 by Par-1/MARK Contributes to Augmentation of AD-Related Phosphorylation and Aβ42-Induced Tau Toxicity , 2016, PLoS genetics.

[44]  O. Pardo,et al.  miR‐515‐5p controls cancer cell migration through MARK4 regulation , 2016, EMBO reports.

[45]  I. Mills,et al.  Salt-Inducible Kinase 2 Regulates Mitotic Progression and Transcription in Prostate Cancer , 2014, Molecular Cancer Research.

[46]  S. Kuang,et al.  Lkb1 Is Indispensable for Skeletal Muscle Development, Regeneration, and Satellite Cell Homeostasis , 2014, Stem cells.

[47]  Q. Ni,et al.  Decreased expression and prognostic role of cytoplasmic BRSK1 in human breast carcinoma: correlation with Jab1 stability and PI3K/Akt pathway. , 2014, Experimental and molecular pathology.

[48]  H. Clevers,et al.  STRAD pseudokinases regulate axogenesis and LKB1 stability , 2014, Neural Development.

[49]  Eric L. Weiss,et al.  Cell Cycle Regulated Interaction of a Yeast Hippo Kinase and Its Activator MO25/Hym1 , 2013, PloS one.

[50]  Chau-Chung Han,et al.  Reversible Acetylation Regulates Salt-inducible Kinase (SIK2) and Its Function in Autophagy* , 2013, The Journal of Biological Chemistry.

[51]  Michael A. Burke,et al.  Snf1‐related kinase inhibits colon cancer cell proliferation through calcyclin‐binding protein‐dependent reduction of β‐catenin , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[52]  Patrick G. A. Pedrioli,et al.  Phosphorylation of CRTC3 by the salt-inducible kinases controls the interconversion of classically activated and regulatory macrophages , 2012, Proceedings of the National Academy of Sciences.

[53]  S. Takashima,et al.  LKB1 and AMP-activated protein kinase: regulators of cell polarity , 2012, Genes to cells : devoted to molecular & cellular mechanisms.

[54]  J. Sznajder,et al.  Salt‐inducible kinase 1 regulates E‐cadherin expression and intercellular junction stability , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[55]  A. Marcus,et al.  STE20-related Kinase Adaptor Protein α (STRADα) Regulates Cell Polarity and Invasion through PAK1 Signaling in LKB1-null Cells* , 2012, The Journal of Biological Chemistry.

[56]  C. Wyatt,et al.  Ion channel regulation by the Lkb1‐AMPK signalling pathway: the key to carotid body activation by hypoxia and metabolic homeostasis at the whole body level , 2012, Advances in experimental medicine and biology.

[57]  J. Chang,et al.  Identification of salt-inducible kinase 3 as a novel tumor antigen associated with tumorigenesis of ovarian cancer , 2011, Oncogene.

[58]  L. Chin,et al.  LKB1 regulates quiescence and metabolic homeostasis of hematopoietic stem cells , 2010, Nature.

[59]  Zchong‐Zcho Wu,et al.  Identification and functional analysis of genes which confer resistance to cisplatin in tumor cells. , 2010, Biochemical pharmacology.

[60]  A. Rosenwald,et al.  Amplification at 11q23 targets protein kinase SIK2 in diffuse large B-cell lymphoma , 2010, Leukemia & lymphoma.

[61]  D. Jin,et al.  [Clinical implication of BRSK2 expression in pancreatic ductal adenocarcinoma]. , 2010, Zhonghua yi xue za zhi.

[62]  M. Taub,et al.  Targeting of renal proximal tubule Na,K-ATPase by salt-inducible kinase. , 2010, Biochemical and biophysical research communications.

[63]  R. Shaw.  Tumor Suppression by LKB1: SIK-ness Prevents Metastasis , 2009, Science Signaling.

[64]  R. Shaw,et al.  The LKB1–AMPK pathway: metabolism and growth control in tumour suppression , 2009, Nature Reviews Cancer.

[65]  W. Hahn,et al.  SIK1 Couples LKB1 to p53-Dependent Anoikis and Suppresses Metastasis , 2009, Science Signaling.

[66]  C. Thornton,et al.  Investigating the Regulation of Brain-specific Kinases 1 and 2 by Phosphorylation* , 2008, Journal of Biological Chemistry.

[67]  B. Turk,et al.  AMPK phosphorylation of raptor mediates a metabolic checkpoint. , 2008, Molecular cell.

[68]  T. Williams,et al.  LKB1 and AMPK in cell polarity and division. , 2008, Trends in cell biology.

[69]  Atsushi Miyawaki,et al.  Visualizing Spatiotemporal Dynamics of Multicellular Cell-Cycle Progression , 2008, Cell.

[70]  H. Bujard,et al.  The Potential for β-Structure in the Repeat Domain of Tau Protein Determines Aggregation, Synaptic Decay, Neuronal Loss, and Coassembly with Endogenous Tau in Inducible Mouse Models of Tauopathy , 2008, The Journal of Neuroscience.

[71]  D. Alessi,et al.  Identification of the sucrose non‐fermenting related kinase SNRK, as a novel LKB1 substrate , 2005, FEBS letters.

[72]  R. DePinho,et al.  The LKB1 tumor suppressor negatively regulates mTOR signaling. , 2004, Cancer cell.

[73]  Jérôme Boudeau,et al.  LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR‐1 , 2004, The EMBO journal.

[74]  Hans Clevers,et al.  MO25α/β interact with STRADα/β enhancing their ability to bind, activate and localize LKB1 in the cytoplasm , 2003 .

[75]  E. Mandelkow,et al.  MARKK, a Ste20‐like kinase, activates the polarity‐inducing kinase MARK/PAR‐1 , 2003, The EMBO journal.

[76]  Jérôme Boudeau,et al.  Complexes between the LKB1 tumor suppressor, STRADα/β and MO25α/β are upstream kinases in the AMP-activated protein kinase cascade , 2003, Journal of biology.

[77]  H C Clevers,et al.  Activation of the tumour suppressor kinase LKB1 by the STE20‐like pseudokinase STRAD , 2003, The EMBO journal.

[78]  N. Horike,et al.  Adipose-specific Expression, Phosphorylation of Ser794 in Insulin Receptor Substrate-1, and Activation in Diabetic Animals of Salt-inducible Kinase-2* , 2003, The Journal of Biological Chemistry.

[79]  M. Seldin,et al.  Hepatocellular carcinoma caused by loss of heterozygosity in Lkb1 gene knockout mice. , 2002, Cancer research.

[80]  G. Drewes,et al.  Microtubule‐Affinity Regulating Kinase (MARK) Is Tightly Associated with Neurofibrillary Tangles in Alzheimer Brain: A Fluorescence Resonance Energy Transfer Study , 2000, Journal of Neuropathology and Experimental Neurology.

[81]  M. Baudry,et al.  The Salt‐Inducible Kinase, SIK, Is Induced by Depolarization in Brain , 2000, Journal of neurochemistry.

[82]  M. Stratton,et al.  A serine/threonine kinase gene defective in Peutz–Jeghers syndrome , 1998, Nature.

[83]  H. Joost,et al.  Molecular cloning and characterization of a novel mammalian protein kinase harboring a homology domain that defines a subfamily of serine/threonine kinases. , 1996, European journal of biochemistry.

[84]  B. Kemp,et al.  Mammalian AMP-activated Protein Kinase Subfamily (*) , 1996, The Journal of Biological Chemistry.

[85]  R. Shaw,et al.  The AMPK-related kinases SIK1 and SIK3 mediate key tumor suppressive effects of LKB1 in NSCLC. , 2019, Cancer discovery.

[86]  R. Welch,et al.  Osteochondral fracture of the proximal palmar middle phalanx in a Thoroughbred. , 1991, Equine veterinary journal.